AWH Stock Overview
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Aspira Women's Health Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$2.06 |
52 Week High | US$6.75 |
52 Week Low | US$1.96 |
Beta | 1.5 |
1 Month Change | -30.64% |
3 Month Change | -43.87% |
1 Year Change | -31.79% |
3 Year Change | -97.62% |
5 Year Change | -86.47% |
Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Aspira Women’s Health slips 23% on common stock offering
Aug 22Aspira Women’s Health GAAP EPS of -$0.07 in-line, revenue of $2.06M misses by $0.34M
Aug 10Is Aspira Women's Health (NASDAQ:AWH) Using Too Much Debt?
Aug 02Is Aspira Women's Health (NASDAQ:AWH) Weighed On By Its Debt Load?
Apr 11Health Check: How Prudently Does Aspira Women's Health (NASDAQ:AWH) Use Debt?
Jan 07Aspira Women's Health (NASDAQ:AWH) Has Debt But No Earnings; Should You Worry?
Sep 24Aspira Women's Health Inc.'s (NASDAQ:AWH) Intrinsic Value Is Potentially 69% Above Its Share Price
Jul 06This Is Why Aspira Women's Health Inc.'s (NASDAQ:AWH) CEO Can Expect A Bump Up In Their Pay Packet
Jun 15Does Aspira Women's Health (NASDAQ:AWH) Have A Healthy Balance Sheet?
May 19Shareholder Returns
AWH | US Medical Equipment | US Market | |
---|---|---|---|
7D | -3.7% | 2.0% | 0.8% |
1Y | -31.8% | 5.1% | 22.5% |
Return vs Industry: AWH underperformed the US Medical Equipment industry which returned 5.1% over the past year.
Return vs Market: AWH underperformed the US Market which returned 22.5% over the past year.
Price Volatility
AWH volatility | |
---|---|
AWH Average Weekly Movement | 10.0% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: AWH's share price has been volatile over the past 3 months.
Volatility Over Time: AWH's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 64 | Nicole Sandford | aspirawh.com |
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company’s products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1’s high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass. It is also developing OvaMDx, a multi-marker test that combines serum proteins, clinical data, and miRNA for assessing the risk of ovarian cancer in women with an adnexal mass; EndoCheck, a protein biomarker designed to identify ovarian endometriomas; and EndoMDx for the identification of endometriosis.
Aspira Women's Health Inc. Fundamentals Summary
AWH fundamental statistics | |
---|---|
Market cap | US$25.65m |
Earnings (TTM) | -US$14.74m |
Revenue (TTM) | US$8.99m |
2.9x
P/S Ratio-1.7x
P/E RatioIs AWH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AWH income statement (TTM) | |
---|---|
Revenue | US$8.99m |
Cost of Revenue | US$3.70m |
Gross Profit | US$5.29m |
Other Expenses | US$20.03m |
Earnings | -US$14.74m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.18 |
Gross Margin | 58.84% |
Net Profit Margin | -163.95% |
Debt/Equity Ratio | -147.6% |
How did AWH perform over the long term?
See historical performance and comparison